Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis. - Wikidata - wikimedia - TriplyDB

Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis.

Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis.

http://www.wikidata.org/entity/Q43772926

about

Glucocorticoids for decompensated heart failure Glucocorticoids for decompensated heart failure Current and Potential Therapeutic Strategies for Hemodynamic Cardiorenal Syndrome Focus on renal congestion in heart failure The kidney in congestive heart failure: 'are natriuresis, sodium, and diuretics really the good, the bad and the ugly?'Hyponatremia and congestive heart failure: a marker of increased mortality and a target for therapy.The role of ultrafiltration in patients with decompensated heart failure.Hyponatremia in heart failure: the role of arginine vasopressin and diuretics.Neurohormonal activation in patients with mild or moderately severe congestive heart failure and effects of ramipril. The Ramipril Trial Study Group.Apparent paradox of neurohumoral axis inhibition after body fluid volume depletion in patients with chronic congestive heart failure and water retention Interactions between furosemide and the renal sympathetic nerves.Prospective development and validation of a model to predict heart failure hospitalisation Clinical, biological, echocardiographic and therapeutic determinants of the length of hospital stay of patients with acute heart failure.Diuretic therapy in elderly heart failure patients with and without left ventricular systolic dysfunction.The acute vascular effects of frusemide in heart failure Hypokalemia and outcomes in patients with chronic heart failure and chronic kidney disease: findings from propensity-matched studies.Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics.Effect of diuretic use on 30-day postdialysis mortality in critically ill patients receiving acute dialysis.Diuretic use in heart failure and outcomes.Immediate effects of bumetanide on systemic haemodynamics and left ventricular volume in acute and chronic heart failure.Continuous versus bolus intermittent loop diuretic infusion in acutely decompensated heart failure: a prospective randomized trial.Acute heart failure volume control multicenter randomized (AVCMA) trial: comparison of tolvaptan and carperitide Cardiorenal syndrome in acute heart failure syndromes.Balancing diuretic therapy in heart failure: loop diuretics, thiazides, and aldosterone antagonists.Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure New therapies for the management of acute heart failure.Analysis of a large cohort of health maintenance organization patients with congestive heart failure.Loop diuretic efficiency: a metric of diuretic responsiveness with prognostic importance in acute decompensated heart failure Renal dysfunction in acute heart failure.Drug treatment of patients with decompensated heart failure.Comparing Sodium Intake Strategies in Heart Failure: Rationale and Design of the Prevent Adverse Outcomes in Heart Failure by Limiting Sodium (PROHIBIT) Study.Management of acute decompensated heart failure.Guidelines for acute decompensated heart failure treatment.Flosequinan in heart failure: acute haemodynamic and longer term symptomatic effects.Lack of significant renal tubular injury despite acute kidney injury in acute decompensated heart failure.Diuretic usage in heart failure: a continuing conundrum in 2005.Heart failure: furosemide--to DOSE or not to DOSE, that is the question Differential mortality association of loop diuretic dosage according to blood urea nitrogen and carbohydrate antigen 125 following a hospitalization for acute heart failure.Interactions between the sympathetic nervous system and the RAAS in heart failure.Ultrafiltration in decompensated heart failure.

P2860

Q24187674-671FEB53-487E-4D31-81B7-87422D90290C Q24202169-CC406E84-28CE-4EA2-9FBF-89A3CFD66D49 Q26753862-BAE17F64-D2D9-42C7-9CB6-C231E27BD2E7 Q26769905-8871E8F6-17D9-4A92-AE18-08CBD4EFB994 Q27011043-835EFB9E-FEA6-49E6-B440-1335FD3ECB49 Q30432267-FAB62A95-BECA-48FB-B972-03AE0B445534 Q30433871-B77F3C72-16F5-4BDA-B654-9024FDFC2E56 Q30448650-726ED02E-0F17-4A74-BA86-62C35F26259A Q33614319-E4247E60-247C-4D04-A40E-9C98D82FE172 Q33614406-B6AE73BB-77C4-4BE1-B1D6-7904A7DCD329 Q33635356-36F2370F-5D94-4895-9C0D-67D9D6A5C9E0 Q33659469-69141086-179C-47F7-82E0-C4B1749496CC Q33666048-37F67E3B-F307-437A-876D-26132C5C100C Q33955190-A596D531-0F1C-457E-BDBA-AF77C1C91424 Q33962025-2EBF14FF-227D-4278-B1D5-C31145433B3C Q34019056-3EF4B923-639D-4A6F-810C-8F6000904D7E Q34118035-04872816-2144-4262-A1F9-B9CCCBF75484 Q34202707-2652A900-8F5B-432D-BBEB-7842F5D52D84 Q34357452-63E6C175-2906-45F3-B717-25D7080B3A4A Q34416884-672B1AD6-4F2D-4514-81DB-2CBCB623CB97 Q34486006-88BAF4BD-58CD-4BF9-B972-6B1053EA0E8A Q34643664-A4594FF8-498F-4048-9D35-235977B17415 Q34665867-F8EB38F3-8318-4CFC-A028-45AFFB12DDDB Q35013821-8046C47F-7172-4BD2-A919-5E9E5AF8F99F Q35071595-FC809D19-FC1A-495E-9650-6E7381CC4392 Q35105845-40039BB4-B371-4F56-814E-1EF584CAD79A Q35113135-D4CD9F0E-C4D9-4C83-A0B8-2A04EF2AA39B Q35285719-C775DE4E-DF03-440A-9465-3F40D780F536 Q35566683-5D5E7941-7FEA-44CE-839B-3FDAD4A06DDD Q35631372-918697F6-C52A-4CAC-BEE4-5A025E713BAA Q35635411-64FF84F0-C43B-4BCA-9F3D-1AAB9650D4E4 Q35659776-D9CC0355-FB10-471B-857E-87EAF1984955 Q35675111-4CF4804B-7538-46B0-9B10-2A5C65A52194 Q35702664-2311017E-786C-4E32-9084-20539832A420 Q35987008-F4DE5535-789A-4613-9C69-6633F029EC93 Q36056333-699614E8-08B9-44BF-BAF0-E998CE592A3B Q36148695-9115C8B6-A03A-4799-A95C-48B6D38A0453 Q36178412-6C250D33-0E93-4A3E-9941-C9B80A74A7F1 Q36203046-4F2FD7CB-2613-4732-AAF8-4500C30DABDF Q36247480-9BC08D06-7C03-41D7-A730-2E99407FCA37

P2860

Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis.

http://www.wikidata.org/entity/Q43772926

description

1985 nî lūn-bûn

@nan

1985年の論文

@ja

1985年学术文章

@wuu

1985年学术文章

@zh

1985年学术文章

@zh-cn

1985年学术文章

@zh-hans

1985年学术文章

@zh-my

1985年学术文章

@zh-sg

1985年學術文章

@yue

1985年學術文章

@zh-hant

name

Acute vasoconstrictor response ...... tion of the neurohumoral axis.

@en

Acute vasoconstrictor response ...... tion of the neurohumoral axis.

@nl

type

label

Acute vasoconstrictor response ...... tion of the neurohumoral axis.

@en

Acute vasoconstrictor response ...... tion of the neurohumoral axis.

@nl

prefLabel

Acute vasoconstrictor response ...... tion of the neurohumoral axis.

@en

Acute vasoconstrictor response ...... tion of the neurohumoral axis.

@nl

P1433

Q43772926-0938D646-C25A-4A03-9A6B-63B7CA3F8542

P1476

Q43772926-154D43A6-A67F-41F4-80BE-7949F4072095

P2093

Q43772926-33AF8F6B-2004-40F2-8F27-56445882212B

Q43772926-510CB012-2902-4350-9357-4EA64CE344FB

Q43772926-58C95EBB-D01D-4FAC-8204-05695D8AC7A8

Q43772926-82B9AAB8-803A-4E92-8A43-6430F4F0B121

Q43772926-AAACB8C9-F8CA-48FC-8CCC-E42B78F4097E

Q43772926-CA446289-B7E2-4055-9323-23D666149FE5

P304

Q43772926-6A12D308-CA87-4B91-BAF9-F12E9E24A496

P31

Q43772926-BD6196A5-E526-478B-8FEF-C479F18DC9C4

P356

Q43772926-956FE237-9EC3-437C-86BE-BFA535E93E66

P407

Q43772926-85498DEB-92F4-4DCB-8841-B95FE21685F6

P433

Q43772926-782CC45C-4975-4D10-B76D-735D150937BB

P478

Q43772926-C53F8748-3F3F-45C0-94F2-3DD8BAAA2974

P577

Q43772926-15C99A3A-72F3-45BD-8450-80F920453A89

P698

Q43772926-44D8233C-C398-4AB8-9607-4BCB263E1BFF

P921

Q43772926-1EA377E7-686C-4488-AF56-6DF392E1A237

Q43772926-2E06ACFE-FE5A-43BD-B763-054E20BAE3A2

P356

0003-4819-103-1-1

P1433

Annals of Internal Medicine

P1476

Acute vasoconstrictor response ...... tion of the neurohumoral axis.

@en

P2093

Cohn JN

http://www.w3.org/2001/XMLSchema#string

Francis GS

http://www.w3.org/2001/XMLSchema#string

Goldsmith SR

http://www.w3.org/2001/XMLSchema#string

Levine TB

http://www.w3.org/2001/XMLSchema#string

Olivari MT

http://www.w3.org/2001/XMLSchema#string

Siegel RM

http://www.w3.org/2001/XMLSchema#string

P304

1-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7326/0003-4819-103-1-1

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P577

1985-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

2860833

http://www.w3.org/2001/XMLSchema#string

P921